Florida-based Veritas Bio won a European patent to cover its delivery technique for RNA-based drugs. The technology enables small pieces of RNA, which can be used to "silence" genetic traits, to reach the liver and treat diseases affecting the organ. The company has a corresponding patent allowed in the U.S. already, and is in the process of filing other applications to expand its RNA-drug capacity, according to a report at HispanicBusiness.com. Inventor Catherine Pachuk told the publication: "Our technology solves one of the biggest hurdles for the development of RNAi and other nucleic acid-based drugs by providing a safe and effective delivery system for effector RNA molecules and other nucleic acid molecules." More